Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Vitamin C and Reduced Interleukin-6 Levels

Research synthesisModerate evidenceSmall effect7 studies · 4 beneficial · 3 neutral · 0 harmful

Across 7 studies, 4 reported beneficial effects of vitamin C on reducing interleukin-6 levels, with effect sizes ranging from small to moderate, while 3 found neutral effects. The median study duration was 28 days, though effects were observed in both acute (1-day) and longer-term (84-day) settings. Most studied populations were clinical (e.g., cardiac surgery, septic shock, hemodialysis patients), and doses ranged from 250 mg to 1000 mg/day.

  • Effective dose range: 250-1000 mg/day
  • Studied populations: clinical populations (cardiac surgery patients, septic shock patients, hemodialysis patients, older women with sarcopenia)

Caveats: Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Several studies used vitamin C in combination with other interventions (thiamine, whey protein, vitamin E), making it difficult to isolate the effect of vitamin C alone. The evidence base includes only 7 studies, and beneficial findings are concentrated in acute clinical settings; generalizability to healthy populations is uncertain.

Generated Jul 10, 2026
Doses used in studies
  • mg/day: 250–1,000 (median 1,000, IQR 6251,000) 3 studies
  • IU/day: 60,000 (median 60,000, IQR 60,00060,000) 1 study
  • g/day: 1 (median 1, IQR 11) 1 study
Time to effect
Median: 4 weeks · IQR 7 days8 weeks · Range 1 day2.8 months — Reported in 5 of 7 studies
Safety in these studies
7 of 7 papers
Back to top